This number has probably increased even more since the poll was conducted, as the medications have become more accessible
Comparison between GLP-1 RA and the GLP-1/GIP dual agonist (tirzepatide) Tirzepatide vs GLP-1 Struggling to lose weight even when you are eating less can feel frustrating
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Impact on AMD A 2025 retrospective published in JAMA Ophthalmology looked at the incidence of developing wet age-related macular degeneration (AMD) three years after initiation of treatment with GLP-1 drugs
Much like in the brain, inflammation is a common feature in several ocular pathologies, particularly those relating to the retina
Markets that treat affordability thresholds as strategic levers, not afterthoughts, will own the volume growth phase of global GLP-1 adoption